AEMD — Aethlon Medical Income Statement
0.000.00%
Last trade - 00:00
- $3.83m
- -$4.15m
- $0.57m
- 26
- 34
- 39
- 24
2019 March 31st | 2020 March 31st | C2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.23 | 0.65 | 0.659 | 0.294 | 0.574 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 6.23 | 7.03 | 8.55 | 10.7 | 12.6 |
Operating Profit | -6 | -6.38 | -7.89 | -10.4 | -12 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -6.22 | -6.38 | -7.89 | -10.4 | -12 |
Net Income After Taxes | -6.22 | -6.38 | -7.89 | -10.4 | -12 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -6.19 | -6.37 | -7.89 | -10.4 | -12 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -6.19 | -6.37 | -7.89 | -10.4 | -12 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -51.3 | -17.4 | -6.52 | -7.06 | -5.79 |